Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center Experience

NCT ID: NCT06564727

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2020-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study was to report our experience with U-VATS resection and to evaluate our surgical outcomes with an analysis of postoperative complications. The investigators also estimate the prognostic factors that influence the morbidity and the conversion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluation of prognostic factors Tuberculosis Hemoptysis Type of aspergilloma presence of complete adherence Procedure

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Aspergillosis Surgery-Complications Thoracic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

study the effect of a treatment and evaluate outcome postoperatively
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Uniportal VATS approach

patient treated by Uniportal VATS technique

Group Type EXPERIMENTAL

Uniportal VATS approach

Intervention Type PROCEDURE

Uniportal VATS resection for simple pulmonary aspergilloma

VATS resection

patients treated by VATS technique

Group Type ACTIVE_COMPARATOR

VATS approach

Intervention Type PROCEDURE

VATS resection for complex pulmonary aspergilloma

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Uniportal VATS approach

Uniportal VATS resection for simple pulmonary aspergilloma

Intervention Type PROCEDURE

VATS approach

VATS resection for complex pulmonary aspergilloma

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Treatment using uniportal VATS

Exclusion Criteria

\- Resection using thoracotomy
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hassan II University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sara WAGUAF

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

sara WAGUAF

Role: PRINCIPAL_INVESTIGATOR

Hassan II University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hassan II University

Casablanca, , Morocco

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Morocco

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

pulmonary aspergilloma

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment Outcomes of Retroperitoneal Sarcoma
NCT06612671 ACTIVE_NOT_RECRUITING